Kimia Abedi

Kimia Abedi

Auto-generated profile, based on publicly available information

Kimia Abedi

University of Cincinnati

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2026 in Biofabrication
Verified
Journal Article
Open access
KAKimia Abedi
Kimia Abedi
CSCheick Sissoko
Cheick Sissoko
SPSirjana Pun
Sirjana Pun
SKSumedha Kappagantula
Sumedha Kappagantula
BZBeatrice Zucca
Beatrice Zucca
RBRiccardo Barrile
Riccardo Barrile
Glioblastoma (GBM) represents the most aggressive and recalcitrant primary malignancy of the central nervous system, characterized by profound intratumoral heterogeneity and a formidable capacity for adaptive therapeutic resistance. This phenotypic plasticity is orchestrated by the tumor microenvironment (TME), which functions as a dynamic clockwork mechanism wherein the hypoxic, perivascular, immune, and neural niches act as interconnected, functionally coupled gears. The synergistic activity of this system is fueled by the combined influence of biochemical signals and key biomechanical forces, specifically interstitial fluid flow, matrix stiffness, and oxygen gradients. While traditional in vivo models have elucidated foundational biological principles, they frequently fail to recapitulate the human-specific, multi-scale dynamics inherent to GBM pathology, thereby hindering translational progress. This review evaluates recent advancements in bioengineering strategies that transition beyond single-niche isolation toward a modular, ‘niche-by-niche’ reconstruction of the GBM TME. We highlight the evolving trajectory of microphysiological systems, where advanced 3D culture and biofabrication methods, such as organoids and bioprinted microfluidic constructs, are leveraged to incorporate multifaceted physicochemical cues in a highly controlled and reproducible manner. Furthermore, we address existing technical limitations and identify critical next steps in the field, including the integration of clinically relevant metrics and scalability. Finally, we propose that these engineered ecosystems serve as innovative tools for the advancement of precision oncology, providing a robust framework for tailoring therapeutic interventions to the unique profile of each patient.

28 May 2026 in Journal of Bioactive and Compatible Polymers
Verified
Journal Article
Closed access
NTNasim Talebinezhad
Nasim Talebinezhad
RIRana Imani
Rana Imani
KAKimia Abedi
Kimia Abedi
MSMehran Solati-Hashjin
Mehran Solati-Hashjin
Skin bioprinting has gained significant attention as a transformative method for treating skin injuries due to its ability to construct complex tissue-engineered structures. This study investigates the effect of varying weight ratios of Oxidized Alginate (OAlg), Gelatin (Gel), and Carboxymethyl Cellulose (CMC) on bioink formulations using extrusion-based bioprinting. Alginate was oxidized with sodium metaperiodate, achieving 10% oxidation. Hydrogels were formulated with OAlg at concentrations of 10%, 15%, and 20% (w/v), while Gel and CMC were held constant at 5% (w/v) and 15% (w/v), respectively. Chemical structure analysis supported the formation of crosslinked interactions within the hydrogels. The optimal formulation, containing 20% (w/v) OAlg, gelled in approximately 30 s and demonstrated good structural stability during printing. Rheological assessments revealed shear-thinning behavior and appropriate viscosity for bioprinting across all formulations. After 28 days, the 20% (w/v) OAlg hydrogel exhibited a 49% degradation rate. Unlike conventional OAlg–Gel systems, the incorporation of CMC provided enhanced viscosity control, improved filament fidelity during extrusion, and improved structural stability during printing without the need for additional ionic crosslinkers. Three-dimensional printing tests demonstrated that this formulation provided superior printing uniformity, and cell viability assays revealed a 93% survival rate for skin fibroblast cells, indicating its potential for further investigation in skin tissue engineering applications.